Global Pharmaceutical Market Outlook Post-Patent Cliff.

BiosimilarsDrug ExpiryMarket StrategyPatent CliffPharmaceutical ForecastsPharmaceutical Market

This report provides an in-depth analysis of shifts in the global pharmaceutical market due to patent expirations occurring from 2023 to 2030. It examines how these changes impact revenue, particularly focusing on biosimilars and generics, affecting key therapy areas such as oncology and immunology. The report discusses geographical impacts across regions like North America, Europe, Asia-Pacific, and more, while highlighting strategic responses from major pharmaceutical companies. Lastly, it explores the regulatory implications and strategies for industry stakeholders to adapt to the evolving market landscape.

Researcher

Plabani Ghosh, Ghost Research

PublishedJanuary 2026

Perspective.

PurposeTo analyze the impact of patent expirations on the global pharmaceutical market and provide strategic insights for stakeholders.

AudiencePharmaceutical companies, policymakers, investors, and healthcare professionals.

Special EmphasisEmphasis on market dynamics, policy implications, strategic adaptations, and innovation.

63Pages of Deep Analysis

95Curated Credible Sources

6Proprietary AI Visuals

9Data Analysis Tables

$495

Plabani Ghosh

6+ Years of Experience

Sectors & Industries

IndustrialsConsumer Staples

Functions & Expertise

Market IntelligenceStrategy & GTM

Have questions? Our Research Desk is here to help

Top Insights.

Patent cliff between 2025 and 2030 threatens significant revenue loss in the pharmaceutical industry.The global market is projected to grow from USD 1.65 trillion in 2024 to USD 2.35 trillion by 2030.Biosimilars and generics are gaining traction, reshaping market dynamics and industry strategies.Strategic responses include portfolio diversification, lifecycle management, and geographic growth.Policy reforms are critical, with emphasis on cost-containment and regulatory streamlining.

Key Questions Answered.

63Pages of Deep Analysis

6Proprietary AI Visuals

95Curated Credible Sources

9Data Analysis Tables

Summary.

Global pharmaceutical sales face a potential $236-400 billion impact by 2030 from patent expirations, with oncological and immunological drugs most affected. The market's value, at $1,646 billion in 2024, is expected to reach $2,350 billion by 2030, driven by AI advancements and expanding emerging markets.

Amid competitive pressures, regions like Asia-Pacific will experience significant growth with an 8.2% CAGR. Strategic shifts include enhanced innovation pipelines and M&A activities. Policymakers aim to streamline biosimilar pathways, reshaping market access and pricing dynamics, especially in high-exposure areas like the US and EU.

Global Pharmaceutical Market Outlook Post-Patent Cliff.

Perspective.

Plabani Ghosh

1What is the patent cliff and its significance in this report?

2How is the global pharmaceutical market projected to grow by 2030?

3What are the key areas at risk due to the patent cliff?

4What strategic responses are companies adopting?

5How are policy and regulatory changes impacting the market?

Summary.